Erythromycin Estolate vs Upadacitinib

## Erythromycin Estolate vs Upadacitinib: Overview

This comparison examines the pharmacological differences between **Erythromycin Estolate** and **Upadacitinib**.

## Mechanism of Action

**Upadacitinib**: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

## Pharmacokinetics

**Half-life**: Erythromycin Estolate — N/A; Upadacitinib — 9-14 hours.

## Chemical Properties

**Molecular Formula**: Erythromycin Estolate — N/A; Upadacitinib — C17H19F3N6O.

**Molecular Weight**: Erythromycin Estolate — N/A; Upadacitinib — 380.3700 g/mol.

**Type**: Erythromycin Estolate — Small molecule; Upadacitinib — Small molecule.